Latest Regulatory Approval News

Freehill Mining shifts focus to cement industry feedstocks, stabilizes operations after plant challenges, and secures fresh capital while reporting promising magnetite test results.

MPR Australia Limited has finalized the sale of its core renewable energy business for approximately $19 million, marking a significant strategic shift. The company now plans to explore options including returning capital to shareholders or acquiring a new business.

Vanadium Resources Limited is advancing its Steelpoortdrift project with fresh leadership, a successful equity raise, and a strategic pivot towards higher-margin concentrate production alongside direct shipping ore.

Avecho Biotechnology advances its pivotal Phase III CBD insomnia trial with 160 patients dosed and secures $2.5 million to accelerate manufacturing and regulatory efforts ahead of a 2026 interim analysis.

Blaze Minerals has mobilised drilling at its promising Loulombo Project in the Republic of the Congo, following exceptional base and critical metals sampling. Meanwhile, its Ugandan Ntungamo Project confirms new critical mineral discoveries, underpinning a recent $2.4 million capital raise.

Variscan Mines secures key regulatory approval and expands its zinc exploration footprint with a major historic drillhole acquisition, backed by a $2.25 million capital raise.

Jameson Resources has made significant strides in advancing its Crown Mountain Hard Coking Coal Project, progressing environmental assessments and Indigenous partnerships while securing fresh capital to support development.

eMetals Limited has progressed its exploration at the Busia Gold Project in Uganda, initiating a second phase of soil sampling to better define a significant gold anomaly. The company ends the quarter with a solid cash position following strategic asset sales.

Santana Minerals reports robust progress on its Bendigo-Ophir Gold Project with an updated Pre-Feasibility Study, strategic land acquisitions, and a substantial capital raise, positioning the project for development in 2026.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

Bowen Coking Coal maintained steady production and sales in Q3 2025 while slashing costs by a third through a new mining model, despite ongoing administration and receivership. The company generated positive operating cash flow and advanced key development projects.

EMVision Medical Devices has successfully closed an oversubscribed Share Purchase Plan, raising $2 million and bringing total recent capital to $14 million. This funding positions the company to advance pivotal clinical trials and regulatory milestones for its innovative neurodiagnostic devices.